CLINICAL_TRIALS
trial_result
· 2021-01-11
Clinical Trial Update: Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA [Phase 4]
Summary
Phase 4 clinical trial update investigating latency antibiotics for previable preterm premature rupture of membranes (PPROM) with ongoing recruitment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Woman's | Conditions: Rupture of Membranes; Delayed Delivery (Following Spontaneous Rupture), Rupture of Membranes; Premature | Phase 4 | Status: RECRUITING